Pentosan Polysulfate As An Inhibitor of Calcium Oxalate Crystal Growth
- 1 October 1984
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 132 (4), 786-788
- https://doi.org/10.1016/s0022-5347(17)49873-9
Abstract
Pentosan polysulfate was studied as a calcium oxalate crystal growth inhibitor. The inhibition from pentosan polysulfate at concentrations from 3.5-110 mg/l was measured in simple inorganic calcium oxalate solutions at pH 5, 6 and 7. Pentosan polysulfate also was mixed with urine at concentrations from 10-350 mg/l and inhibition determined. Measurement of calcium oxalate crystal growth inhibition was performed in a seeded crystal growth system. One inhibitory unit (concentration of pentosan polysulfate necessary to give a 50% reduction in the rate of crystal growth) was 5.7 .+-. 2 mg/l at pH 5, 7.2 .+-. 1.1 mg/l at pH 6 and 6.0 .+-. 2.1 mg/l at pH 7. Urine-pentosan polysulfate mixtures showed more inhibitory activity than the predicted inhibition present. Addition of pentosan polysulfate to urine at a concentration of 10 mg/l increased the inhibitory activity from 45 .+-. 3 to 59 .+-. 3 IU/l. Pentosan polysulfate is a potent calcium oxalate crystal growth inhibitor in urine at physiologic pH levels. If the urinary concentration of pentosan polysulfate after oral administration reaches 10 mg/l, the increase in inhibitory activity in urine that may occur might be important in the treatment of patients who form calcium oxalate calcium within the urinary tract.This publication has 8 references indexed in Scilit:
- Successful Treatment of Interstitial Cystitis with Sodium pentosanpolysulfateJournal of Urology, 1983
- The synthesis and characterization of N-sulfo-2-amino tricarballylate: An analog of phosphocitrate and inhibitor of calcificationAnalytical Biochemistry, 1983
- Urinary Crystal Growth: Effect of Inhibitor MixturesClinical Science, 1981
- Studies on the different mechanisms by which heparin and polysulphated xylan (PZ 68) inhibit blood coagulation in manThrombosis Research, 1981
- Treatment of Calcium Urolithiasis with Diphosphonate: Efficacy and HazardsJournal of Urology, 1979
- Urinary Saturation Measurements in Calcium NephrolithiasisAnnals of Internal Medicine, 1979
- The Influence of Disodium Ethane-1-Hydroxy-1,1-Diphosphonate (Ehdp) on the Development of Experimentally Induced Urinary Stones in RatsClinical Science, 1972
- Heparin Metabolism: Isolation and Characterization of UroheparinNature, 1966